Definition Of Lymphoma

We do not easily arrive at a complete and simple definition of lymphoma unless we begin with the basics and work our way into the more complex aspects of this disease, and even then there is no certainty that it will be understood.

For starters, lymphoma is a malignancy that occurs in lymphocytes, the white blood cells that patrol our body in a network of vessels that make up part of the lymphatic system. This network traverses the entire body, meaning that lymphoma can develop nearly anywhere in the body, provided the cells are there.

Definition Of Lymphoma: The lymphatic system

The lymphatic system is part of our immune system and it includes primary organs and secondary organs. The lymph system's primary organs are the thymus and the bone marrow. The lymph system's secondary organs include the spleen and the many hundreds of lymph nodes located throughout the body. The lymphocytes traverse our body, passing through these organs at various stages of their life cycles.

Definition Of Lymphoma: Cell division and apoptosis

Part of that life cycle involves beginning a process that allows the cell, in a manner of speaking, to commit suicide, known as apoptosis. This is an important process, and is necessary for our good health that we continue to produce lymphocytes and that they continue to patrol our bodies looking for pathogens and that they eventually die.

Among the many reasons this is important is because when a lymphocyte refuses to die, there is a big problem brewing: a lymphocyte that won't die may be able to undergo mitosis—divide and multiply, in other words. And when a cell which has mutated to the point that it can dodge the pre-programmed cell suicide, and when that cell can safely then divide, we have an uncontrolled proliferation of malignant cells—a very basic, fundamental definition of cancer. in this case, cancer occurring in lymph cells.

To put it briefly, in lymphoma, cancerous lymphocytes begin to proliferate, rather than die. Thus, in a definition of lymphoma, it is considered a lymphoproliferative disorder.

When this little mutation emerges from other cells in the body—breast tissue cells, skin cells, brain cells—it is a cancer of those cells—breast, skin, brain cancers.

Definition Of Lymphoma: Lymphoma subtypes

Lymphoma subtypes—of which there are literally dozens and dozens—are generally named in part by how they look. When we see subtypes like 'anaplastic large cell lymphoma' this merely means that under the microscope, the diseased cells are misshapen (anaplastic) and bigger in size than healthy cells (large).

The greater categorization for lymphomas is beyond the scope of this entry, and in fact is in a near-constant flux, as researchers learn more and more about what makes lymphomas that form in one place the same or different from lymphomas that form in another place.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap